Substance
BORTEZOMIB
Global reference: every product and company linked to this substance.
- cas: 179324-69-7
- ncit: C1851
- pubchem_cid: 387447
- rxnorm: 358258
- unii: 69G8BD63PP
bortezomib [INN] · BORTEZOMIB [JAN] · BORTEZOMIB [USAN] · Bortezomib [WHO-DD] · BORTEZOMIB ACCORD · BORTEZOMIB HYDRATE [JAN] · LDP-341 · NSC-681239 · PS-341 · VELCADE
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- BORTEZOMIB · DR. REDDY'S LABORATORIES LTD COMMON STOCK
- VELCADE · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
Companies holding this asset (6)
- BAXTER INTERNATIONAL INC. COMMON STOCK
- DR. REDDY'S LABORATORIES LTD COMMON STOCK
- MAIA BIOTECHNOLOGY INC. COMMON STOCK
- PFIZER INC. COMMON STOCK
- TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES